The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.
Hansini, a high school student from Manthan School, Hyderabad has been awarded the prestigious Cambridge Outstanding Learners Award in the World Topper category for Economics at the AS Level. This ...
Moderna (NASDAQ:MRNA) traded lower in the premarket on Wednesday after Goldman Sachs downgraded the COVID-19 vaccine maker to Neutral from Buy, citing a lack of clarity over its revenue outlook.
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application ...
Merck is investigating WELIREG in rare oncologic diseases, RCC and other tumor types through a broad clinical development program, including in Phase 2 and 3 trials evaluating WELIREG as monotherapy ...
Frazier, whose extended tenure as Merck CEO will have past the 10-year milestone when he steps down on 30 June, said the results were "solid" given the high proportion of physician-administered ...
The combination of Merck’s Keytruda and Eisai’s Lenvima failed to prolong patients’ lives versus the comparator in another cancer study, but the companies ...
Following four straight sessions of gains, Moderna (NASDAQ:MRNA) shares continued to trade higher in the premarket on Friday after the company received a tender to supply its COVID-19 vaccine in the ...
As a young physiology student Tipu Aziz was inspired by watching grainy videos from the 1970s showing patients undergoing brain surgery for movement disorders such as Parkinson’s disease. The films ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback